Drug safety update: hyoscine butylbromide injection
Pharmacy Magazine,
1 Min
Drug safety update: hyoscine butylbromide injection
Pharmacy Magazine,
1 Min
In News
Follow this topic
Bookmark
Record learning outcomes
The MHRA has issued the following Drug Safety Update for hyoscine butylbromide (Buscopan) injection: risk of serious adverse effects in patients with underlying cardiac disease.
Prescribing information has been updated to help to minimise the risk of serious adverse reactions in patients with cardiac disease. More information here.
Copy Link
Record my learning outcomes
Save for later
In News
Stay up to date with all the news, learning and insight in the world of pharmacy.